TipRanks
BioAdaptives (BDPT)
OTHER OTC:BDPT
US Market

BioAdaptives (BDPT) Income Statement

25 Followers

BioAdaptives Income Statement

Last quarter (Q2 2026), BioAdaptives's total revenue was $4.99K, an increase of 54.95% from the same quarter last year. In Q2, BioAdaptives's net income was $150.09K. See BioAdaptives’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 18.28K$ 12.67K$ 28.57K$ 17.18K$ 19.78K
Gross Profit
$ 12.50K$ 4.03K$ 10.82K$ 7.13K$ 10.11K
Operating Expenses
$ 1.05M$ 606.12K$ 239.74K$ 429.03K$ 636.51K
Depreciation and Amortization
$ 4.00K$ 1.94K$ 28.17K$ 62.15K$ 133.79K
EBITDA
$ -1.03M$ -582.15K$ -521.00K$ -544.00K$ -644.00K
Operating Income
$ -1.04M$ -602.00K$ -229.00K$ -422.00K$ -636.00K
Other Income/Expenses
$ -515.73K$ -302.67K$ -484.00K$ -474.00K$ -414.00K
Pretax Income
$ -1.56M$ -904.76K$ -712.00K$ -896.00K$ -1.05M
Net Income
$ -1.56M$ -899.00K$ -712.00K$ -896.00K$ -1.05M
Per Share Metrics
Basic EPS
$ -0.15$ -0.11$ -0.12$ -1.27$ -4.67
Diluted EPS
$ -0.15$ -0.11$ -0.12$ -1.27$ -4.67
Weighted Average Shares Outstanding
10.07M 8.22M 5.97M 706.74K 224.95K
Weighted Average Shares Outstanding (Diluted)
10.07M 8.22M 5.97M 706.74K 224.95K
Currency in USD

BioAdaptives Earnings and Revenue History